Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data-Reference-Cited by-同舟云学术

Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data

Published:2021-10-18 Issue:4 Volume:196 Page:932-938
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Halligan Sarah J.¹^ORCID,Grainge Matthew J.²^ORCID,Martinez‐Calle Nicolas³,Fox Christopher P.³,Bishton Mark J.³^ORCID

Affiliation:

1. Nottingham University Hospitals NHS Trust NottinghamUK

2. Population and Lifespan Sciences School of Medicine University of Nottingham NottinghamUK

3. Department of Clinical Haematology Nottingham University Hospitals NHS Trust Nottingham UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17896

Reference18 articles.

1. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

2. Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials

3. Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95

4. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial;European Journal of Cancer;2023-09

2. Peripheral T-Cell Lymphomas: Therapeutic Approaches;Cancers;2022-05-08